MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11306-018-1387-z

Медицинская библиотека · Metabolomics : Official journal of the Metabolomic Society · 2018

Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome.

Li Wei-Wei, Yang Yan, Dai Qi-Gang, Lin Li-Li, Xie Tong, He Li-Li, Tao Jia-Lei, Shan Jin-Jun, Wang Shou-Chuan

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

INTRODUCTION

Neonatal cholestatic disorders are a group of hepatobiliary diseases occurring in the first 3 months of life. The most common causes of neonatal cholestasis are infantile hepatitis syndrome (IHS) and biliary atresia (BA). The clinical manifestations of the two diseases are too similar to distinguish them. However, early detection is very important in improving the clinical outcome of BA. Currently, a liver biopsy is the only proven and effective method used to differentially diagnose these two similar diseases in the clinic. However, this method is invasive. Therefore, sensitive and non-invasive biomarkers are needed to effectively differentiate between BA and IHS. We hypothesized that urinary metabolomics can produce unique metabolite profiles for BA and IHS.

OBJECTIVES

The aim of this study was to characterize urinary metabolomic profiles in infants with BA and IHS, and to identify differences among infants with BA, IHS, and normal controls (NC).

METHODS

Urine samples along with patient characteristics were obtained from 25 BA, 38 IHS, and 38 NC infants. A non-targeted gas chromatography-mass spectrometry (GC-MS) metabolomics method was used in conjunction with orthogonal partial least squares discriminant analysis (OPLS-DA) to explore the metabolomic profiles of BA, IHS, and NC infants.

RESULTS

In total, 41 differentially expressed metabolites between BA vs. NC, IHS vs. NC, and BA vs. IHS were identified. N-acetyl-D-mannosamine and alpha-aminoadipic acid were found to be highly accurate at distinguishing between BA and IHS.

CONCLUSIONS

BA and IHS infants have specific urinary metabolomic profiles. The results of our study underscore the clinical potential of metabolomic profiling to uncover metabolic changes that could be used to discriminate BA from IHS.

Для цитирования: Li Wei-Wei, Yang Yan, Dai Qi-Gang, Lin Li-Li, Xie Tong, He Li-Li, Tao Jia-Lei, Shan Jin-Jun, Wang Shou-Chuan. Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome.. Metabolomics : Official journal of the Metabolomic Society. 2018. DOI: 10.1007/s11306-018-1387-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.